Weekly self-monitoring feedback and goal prompts to support weight loss

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This micro-randomized factorial trial gives all participants a Weight Loss 101 session and tools to self-monitor diet, physical activity, and weight using a smartphone-linked scale and Fitbit. Each week participants receive a standard feedback message about how often they tracked and their weight trend, and are randomized to receive or not receive four additional feedback components (calorie goal feedback, dietary quality feedback, activity feedback, and a goal-setting prompt). The trial compares which message components improve next-week self-monitoring, goal adherence, and short-term weight change, and examines whether message effects differ by participant characteristics or context. Data are collected remotely via the app and devices, with weekly randomization of message content to build evidence for the most effective feedback strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age greater than or equal to 18 years
* BMI greater than or equal to 25.0 kg/m2
* Weight less than or equal to 175 kg (due to scale limit)
* Own a smartphone compatible with Fitbit (e.g., an Apple iPhone running iOS 16.4 or higher or Android smartphone running Android 11 or higher) with a cellular and data plan

Exclusion Criteria:

* Weight greater than 175 kg (due to a weight limit of the study-provided scale)
* Smartphone device owned deemed incompatible with the Fitbit App
* History of bariatric surgery or plans to obtain bariatric surgery during the study period
* Current use of weight loss medications, or use of weight loss medications in the 6 months prior to initial pre-screening
* Currently participating in a weight-loss program
* Weight loss of greater than or equal to 10 lbs in the 6 months prior to initial pre-screening
* Physical limitations that prevent walking at a brisk pace for at least 10 minutes without stopping
* Use of a pacemaker or other implanted medical device
* Currently pregnant
* Currently breastfeeding
* Less than 1-year post-partum
* Plans to become pregnant within the study period
* Lack of written confirmation that the potential participant has discussed study participation with their physician if they have been diagnosed with diabetes, hypertension, or has have a history of coronary heart disease
* One or more study participants living in the household (enrollment limited to one participant per household)
* Medical conditions that contraindicate weight loss or prevent completion of the study (e.g., current diagnosis of cancer or terminal illness, dementia, etc.)
* Recent (in the past 6 months) changes in medications that affect weight
* Self-reported eating disorder within past 5 years
* Unable to complete the 17-week study (due to plans to relocate during the study period, etc.)
* Unable or unwilling to provide informed consent
* Unable to read English at the 5th grade level
* Unwilling to accept random assignment
* Unable or unwilling to download the study smartphone application, wear the physical activity monitor, or use the study e-scale
* Failure to complete baseline assessment measures
* Failure to complete at least 4 out of 6 days of self-monitoring dietary and weight self-monitoring during the behavioral run-in period
* Any other condition(s) which, in the opinion of the Principal Investigator, would adversely affect participation in the study

Where it's running

• Advocate Aurora Research Institute
  Milwaukee, Wisconsin, United States Recruiting

Study contacts

• Principal investigator: Kathryn M. Ross, Ph.D., M.P.H. — Aurora Research Institute LLC
• Study coordinator: Tejashri Ganbote, MBA, MBBS
• Email: Tejashri.ganbote@aah.org
• Phone: 414-363-1229

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Dramatherapy Added to Physical Activity for Obesity Care

  This trial tests whether adding dramatherapy to a standard adapted physical activity program helps adults with obesity in bariatric or medical care improve psychosocial well‑being and weight-related outcomes.

  Recruiting Universite du Littoral Cote d'Opale · Blendecques, Hauts-de-France · NCT07685483

• Integrated Traditional Chinese and Western medicine care for adults with obesity

  This project will try combining traditional Chinese medicine and Western medical care in adults with obesity to see how well that combination works in everyday clinical practice.

  Recruiting Hubei Hospital of Traditional Chinese Medicine · Wuhan, Hubei · NCT07448090

• Side-to-side duodeno-ileostomy with magnets versus semaglutide for adults with obesity and type 2 diabetes

  This trial tests whether a magnet-assisted side-to-side duodeno-ileostomy surgery or the medication semaglutide works better to improve blood sugar control and weight in adults with obesity and type 2 diabetes.

  Recruiting GT Metabolic Solutions, Inc. · Westmount, Quebec · NCT07317115

• Different weekly feedback messages to support weight loss

  This project will test whether different weekly feedback messages delivered via a smartphone app help adults with overweight or obesity lose weight.

  Recruiting University of Virginia · Charlottesville, Virginia · NCT07292389

• How incretin treatments affect muscle mass and function in people with overweight or obesity

  This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.

  Recruiting Radboud University Medical Center · Amsterdam and 1 other locations · NCT07929831

• Dose find for remimazolam plus alfentanil for gastroscopy in obese adults

  This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07925684

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.